Loading...
Golimumab for the treatment of ulcerative colitis
The introduction of therapeutic antibodies against tumor necrosis factor (TNF) had a major impact on the treatment of ulcerative colitis (UC). Infliximab and adalimumab are powerful agents that are used for remission induction and maintenance therapy in UC and have an acceptable safety profile. Howe...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3958527/ https://ncbi.nlm.nih.gov/pubmed/24648749 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CEG.S48741 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|